Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Administer standard doses
Drug 1
Drug 1 dose
300 mg orally x 1
Drug 1 effect
AUC increased 94%; Cmax increased 130%
Drug 2
Drug 2 dose
800/150 mg once daily (in fed state)
Drug 2 effect
Not reported
Mechanism
Inhibition of CYP3A4 by cobicistat
Clinical Effects
No clinically significant effect expected
Info Source
